These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 22687758)
21. Potential of hydrogels based on poly(ethylene glycol) and sebacic acid as orthopedic tissue engineering scaffolds. Kim J; Hefferan TE; Yaszemski MJ; Lu L Tissue Eng Part A; 2009 Aug; 15(8):2299-307. PubMed ID: 19292677 [TBL] [Abstract][Full Text] [Related]
22. Heparin-decorated, hyaluronic acid-based hydrogel particles for the controlled release of bone morphogenetic protein 2. Xu X; Jha AK; Duncan RL; Jia X Acta Biomater; 2011 Aug; 7(8):3050-9. PubMed ID: 21550426 [TBL] [Abstract][Full Text] [Related]
23. Control of growth factor binding and release in bisphosphonate functionalized hydrogels guides rapid differentiation of precursor cells in vitro. Kootala S; Zhang Y; Ghalib S; Tolmachev V; Hilborn J; Ossipov DA Biomater Sci; 2016 Feb; 4(2):250-4. PubMed ID: 26610690 [TBL] [Abstract][Full Text] [Related]
24. Minimum structural requirements for BMP-2-binding of heparin oligosaccharides. Smith RAA; Murali S; Rai B; Lu X; Lim ZXH; Lee JJL; Nurcombe V; Cool SM Biomaterials; 2018 Nov; 184():41-55. PubMed ID: 30205243 [TBL] [Abstract][Full Text] [Related]
25. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Pike DB; Cai S; Pomraning KR; Firpo MA; Fisher RJ; Shu XZ; Prestwich GD; Peattie RA Biomaterials; 2006 Oct; 27(30):5242-51. PubMed ID: 16806456 [TBL] [Abstract][Full Text] [Related]
27. Critical assessment of rhBMP-2 mediated bone induction: an in vitro and in vivo evaluation. Kisiel M; Ventura M; Oommen OP; George A; Walboomers XF; Hilborn J; Varghese OP J Control Release; 2012 Sep; 162(3):646-53. PubMed ID: 22902595 [TBL] [Abstract][Full Text] [Related]
28. Osteogenic potential of BMP-2-releasing self-assembled membranes. Chung EJ; Chien KB; Aguado BA; Shah RN Tissue Eng Part A; 2013 Dec; 19(23-24):2664-73. PubMed ID: 23790163 [TBL] [Abstract][Full Text] [Related]
29. BMP-2 Derived Peptide and Dexamethasone Incorporated Mesoporous Silica Nanoparticles for Enhanced Osteogenic Differentiation of Bone Mesenchymal Stem Cells. Zhou X; Feng W; Qiu K; Chen L; Wang W; Nie W; Mo X; He C ACS Appl Mater Interfaces; 2015 Jul; 7(29):15777-89. PubMed ID: 26133753 [TBL] [Abstract][Full Text] [Related]
30. Perlecan domain I-conjugated, hyaluronic acid-based hydrogel particles for enhanced chondrogenic differentiation via BMP-2 release. Jha AK; Yang W; Kirn-Safran CB; Farach-Carson MC; Jia X Biomaterials; 2009 Dec; 30(36):6964-75. PubMed ID: 19775743 [TBL] [Abstract][Full Text] [Related]
31. Heparin microparticle effects on presentation and bioactivity of bone morphogenetic protein-2. Hettiaratchi MH; Miller T; Temenoff JS; Guldberg RE; McDevitt TC Biomaterials; 2014 Aug; 35(25):7228-38. PubMed ID: 24881028 [TBL] [Abstract][Full Text] [Related]
32. Comparison between heparin-conjugated fibrin and collagen sponge as bone morphogenetic protein-2 carriers for bone regeneration. Yang HS; La WG; Cho YM; Shin W; Yeo GD; Kim BS Exp Mol Med; 2012 May; 44(5):350-5. PubMed ID: 22322342 [TBL] [Abstract][Full Text] [Related]
33. Synthetic design of growth factor sequestering extracellular matrix mimetic hydrogel for promoting in vivo bone formation. Yan HJ; Casalini T; Hulsart-Billström G; Wang S; Oommen OP; Salvalaglio M; Larsson S; Hilborn J; Varghese OP Biomaterials; 2018 Apr; 161():190-202. PubMed ID: 29421555 [TBL] [Abstract][Full Text] [Related]
34. Is Heparin Effective for the Controlled Delivery of High-Dose Bone Morphogenetic Protein-2? Kim RY; Lee B; Park SN; Ko JH; Kim IS; Hwang SJ Tissue Eng Part A; 2016 May; 22(9-10):801-17. PubMed ID: 27098389 [TBL] [Abstract][Full Text] [Related]
35. Sustained release of rhBMP-2 from microporous tricalciumphosphate using hydrogels as a carrier. Kissling S; Seidenstuecker M; Pilz IH; Suedkamp NP; Mayr HO; Bernstein A BMC Biotechnol; 2016 May; 16(1):44. PubMed ID: 27206764 [TBL] [Abstract][Full Text] [Related]
36. Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering. Yilgor P; Tuzlakoglu K; Reis RL; Hasirci N; Hasirci V Biomaterials; 2009 Jul; 30(21):3551-9. PubMed ID: 19361857 [TBL] [Abstract][Full Text] [Related]
37. Efficient in vivo bone formation by BMP-2 engineered human mesenchymal stem cells encapsulated in a projection stereolithographically fabricated hydrogel scaffold. Lin H; Tang Y; Lozito TP; Oyster N; Wang B; Tuan RS Stem Cell Res Ther; 2019 Aug; 10(1):254. PubMed ID: 31412905 [TBL] [Abstract][Full Text] [Related]
38. Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. Jeon O; Song SJ; Yang HS; Bhang SH; Kang SW; Sung MA; Lee JH; Kim BS Biochem Biophys Res Commun; 2008 May; 369(2):774-80. PubMed ID: 18313401 [TBL] [Abstract][Full Text] [Related]
39. Controlled release of bone morphogenetic protein-2 enhances recruitment of osteogenic progenitor cells for de novo generation of bone tissue. Kimura Y; Miyazaki N; Hayashi N; Otsuru S; Tamai K; Kaneda Y; Tabata Y Tissue Eng Part A; 2010 Apr; 16(4):1263-70. PubMed ID: 19886805 [TBL] [Abstract][Full Text] [Related]
40. Synergistic effects of the dual release of stromal cell-derived factor-1 and bone morphogenetic protein-2 from hydrogels on bone regeneration. Ratanavaraporn J; Furuya H; Kohara H; Tabata Y Biomaterials; 2011 Apr; 32(11):2797-811. PubMed ID: 21257197 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]